Igor Bilinsky - 16 Oct 2023 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Chief Operating Officer
Signature
/s/ Igor Bilinsky
Issuer symbol
IOVA
Transactions as of
16 Oct 2023
Net transactions value
-$4,980
Form type
4
Filing time
18 Oct 2023, 20:04:11 UTC
Previous filing
17 Jul 2023
Next filing
18 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Options Exercise $0 +2,813 +10% $0.000000 30,026 16 Oct 2023 Direct F1
transaction IOVA Common Stock Tax liability $4,980 -1,395 -4.6% $3.57 28,631 16 Oct 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Restricted Stock Units Options Exercise $0 -2,813 -17% $0.000000 14,064 16 Oct 2023 Common stock 2,813 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
F2 Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities.
F3 Represents common stock remaining after deducting the common stock withheld for taxes.
F4 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F5 The remaining RSUs will vest in five equal quarterly installments.